HuaXi Pharm investment, marketing by Hongwan Mednet
☆ Repaglinide (Repaglinide, trade name: repaglinide)
☆ Mitiglinide calcium (Mitiglinide Calcium, trade name: Law Di)
☆ Nateglinide (Nateglinide)

  With economic development, China's urbanization process accelerated greatly in the last decade, the proportion of urban population increased from 37.7% in 2001 to 46.6% in 2009. Urbanization has changed people’s lifestyle greatly. In cities, cars or subway are means of transport mainly, and most people work mainly in mental work. That reduces physical activity greatly every day. The high pace of city life makes people a lot of pressure and a long term of high stress, while the superior material life but also makes it the high proportion of fat intake. All these have increased the urban population the risk of suffering from high blood sugar. In addition, urbanization has also led to the increase of proportion of obese or overweight population. According to the diagnostic criteria of World Health Organization, the survey data of Chinese Medical Association 2008 shows that 25.1% of China's population is overweight, and 5% of that is obese. Comparing with 1992 and 2002 survey data, the overweight and obesity proportion of China are increased significantly.
  According to the forecasts of Chinese Medical Association Diabetes Branch, the diseasing rate of aging population over the age of 60 is more than 20%, which is larger for 10 times than that of 20 to 30 year olds. Excluding other factors, adding each additional 10 years of age, the prevalence of diabetes increased 68%. From 2001 to 2009, China's proportion of elderly population over 65 increased from 7.1% to 8.5%, and the elderly to the total proportion of the population has gradually increased.
  Comparing with whites, Asian people are more susceptible to diabetes. According to the information the Chinese Medical Association, comparing with whites, the risk ratio of diabetes of Asians is larger than 1.6, after the gender, age, BMI Index (Body Mass Index, body mass index) of the differences was adjusted. In developed countries, the risk of diabetes in Chinese descendants larger than that in Caucasians. That also support that the Chinese people are susceptible diabetes. Accroding to a survey in the mid-1990s abroad, the diabetes prevalence of Chinese neighborhood is between 7 and 11% in Singapore, Hong Kong and Taiwan area, and the diabetes prevalence of Chinese in Mauritius is more than 11%. These data are higher than the global average prevalence which is less than 5%.
  Diabetes is the fourth largest disease that causes death. According to IDF statistics, in 2000 151 million diabetics worldwide, there are currently about 285 million diabetic patients, in 2030 the global diabetes will increase to 500 million. Diabetes has not only developed the "diseases of affluence", the economy is off diabetes in developing countries is increasingly becoming a "disaster area", the world's largest number of diabetic patients before the three countries as China, India and the United States.
  As the world's most populous country, with the sustained economic development and changes of lifestyle and environment, China's number of diabetic patients is increasing rapidly. Chinese Medical Association Diabetes Branch has screened 48,431 people aged 20 or more for diabetes in 2007 and 2008 in in 14 provinces of the East and West China. And diabetes and predicaments in China was found the prevalence rate of 9.7% and 15.5 %. According to this data it is estimated that there is about 92.4 million diabetic patients and nearly 150 million pre-diabetes patients in China, the equivalent of every one of four adults in China has high blood sugar. The number of diabetic patients in China, which is larger than that in India, accounts for 1/3 of global amount.  China has become the country with most diabetic patients, while 148 million people are in pre-diabetes. This survey was proposed by Professor Yang Wenying of the Endocrine and Metabolic Diseases Center, Sino-Japanese Friendship Hospital. This result was published on the internationally renowned medical journal "New England Journal of Medicine" March 25, 2010. Among them, patients with type 2 diabetes in China accounted for more than 90%, type 1 for about 5% and gestational diabetes for about 5%, and other special types of about 0.7%. Prevalence rate of diabetes in rich region was significantly higher than that in poverty-stricken areas; cities incidence is higher than the incidence in rural areas. The urban population of diabetic patients is 49.3 million, while rural population of of diabetic patients is 43.1 million; obese diabetic patients is more than normal diabetic patients; elder diabetic patients are more than young diabetic patients; men has more risk than women; and patients tends to be younger: the number of diabetic patients 30 years of age increased rapidly, patients of 40 years old increase in new cases, about 87% of all diabetes patients are older than 40 years, and the peak age of taking diabetes is 50 to 70 years.
   60.7% of Chinese diabetes patients were undiagnosed or have delayed treatment. With the popularity of diabetes education, the total number of diabetic patients in China will increase greatly in next 30 years. According to the Chinese Medical Association Diabetes Branch, it’s estimated that type 2 diabetes has just started to populate in China. It predicted that there will add 3000 cases of diabetes a day. That means 1 million new patients each year. According to the Ministry of Health statistics, China's urban diabetes prevalence increased from 6.4 ‰ of 1993 to 27.5 ‰ of 2008, which is an increase of 4.3 times; the prevalence of diabetes in rural areas grew more rapidly, from 0.7 ‰ in 1993  to 4.8 ‰ of 2008, which is an increase of 6.9 times.
  According to IMS statistics, the global diabetes market in 2005 reached $ 18.842 billion. Compared with $ 16.798 billion in 2004, it increased 12.17%. It reached $ 21.309 billion in 2006 , which is an increase of 13.09%. in 2007 to $ 24.283 billion, an increase of 13.96%; 2008 to $ 27.267 billion, an increase of 12.29%; $ 30 billion in 2009, reaching $ 30.406 billion in the global pharmaceutical market ranked No. 4. Its future will be expected 10 to 15% growth rate.
  With the increasing prevalence of diabetes and the increase of people's living standards and medical standards, China's diabetes drug market expanded every year. In 2007 it reached ¥7.495 billion, which means an increase of 20.98%. And in 2008 it reached ¥8.52 billion, which means an increase of 13.68%. In 2009 it reached ¥9.806 billion, which means an increase of 15.09%. And it was expected to reach ¥200 billion by 2015.